Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae

Chinese Journal of Contemporary Pediatrics

Volumn 16, Issue 4, 2014, Pages 401-405

  Wu, Yue Jin ^a   Sun, Jie ^a   Zhang, Jian Hua ^a   Feng, Ling Ling ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Child*; Glucocorticoid; Lobar pneumonia; Mycoplasma pneumoniae; Pulmonary function

Indexed keywords

AZITHROMYCIN; C REACTIVE PROTEIN; DEXAMETHASONE; INTERLEUKIN 2; INTERLEUKIN 6; PREDNISONE;

ADJUVANT THERAPY; ARTICLE; BODY TEMPERATURE; CANCER HORMONE THERAPY; CHILD; CONTROLLED STUDY; COUGHING; DRUG DOSE REDUCTION; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HUMAN; LOBAR PNEUMONIA; LUNG FUNCTION; MYCOPLASMA PNEUMONIAE; NONHUMAN; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; THORAX RADIOGRAPHY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-6; LUNG; MALE; PNEUMONIA; PNEUMONIA, MYCOPLASMA;

EID: 84901797923     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: 10.7499/j.issn.1008-8830.2014.04.019     Document Type: Article

References (16)

1. Touati A, Pereyre S, Bouziri A, et al. Prevalence of Mycoplasma pneumoniae-associated respiratory tract infections in hospitalized children: results of a 4-year prospective study in Tunis[J]. Diagn Microbiol Infect Dis, 2010, 68(2): 103-109.
2. Kjaer BB, Jensen JS, Nielsen KG, et al. Lung function and bronchial responsiveness after mycoplasma pneumoniae infection in early childhood [J]. Pediatric Pulmonol, 2008, 43(6): 567-575. (Pubitemid 351813010)